Uharek L - Search Results

1

A new HLA-B*52 allele, B*52:23, detected in a patient before bone marrow transplantation.

Todorova K, Schulze H, Ciroki J, Uharek L, Salama A, Schönemann C. Todorova K, et al. Among authors: uharek l. Tissue Antigens. 2011 Dec;78(6):455-6. doi: 10.1111/j.1399-0039.2011.01746.x. Epub 2011 Jul 18. Tissue Antigens. 2011. PMID: 21762112

2

Detection of a novel HLA-A allele, designated A*02:334.

Schulze H, Todorova K, Cirocki J, Uharek L, Schönemann C. Schulze H, et al. Among authors: uharek l. Tissue Antigens. 2012 Aug;80(2):191. doi: 10.1111/j.1399-0039.2012.01900.x. Epub 2012 Jun 6. Tissue Antigens. 2012. PMID: 22671565

3

Patients at high risk for CMV infection and disease show delayed CD8+ T-cell immune recovery after allogeneic stem cell transplantation.

Ganepola S, Gentilini C, Hilbers U, Lange T, Rieger K, Hofmann J, Maier M, Liebert UG, Niederwieser D, Engelmann E, Heilbronn R, Thiel E, Uharek L. Ganepola S, et al. Among authors: uharek l. Bone Marrow Transplant. 2007 Mar;39(5):293-9. doi: 10.1038/sj.bmt.1705585. Epub 2007 Jan 29. Bone Marrow Transplant. 2007. PMID: 17262060

4

Graft-versus-leukemia activity after bone marrow transplantation does not require graft-versus-host disease.

Glass B, Uharek L, Gassmann W, Focks B, Bolouri H, Loeffler H, Mueller-Ruchholtz W. Glass B, et al. Among authors: uharek l. Ann Hematol. 1992 Jun;64(6):255-9. doi: 10.1007/BF01695466. Ann Hematol. 1992. PMID: 1637877

5

Eradication of residual disease by administration of leukemia-specific T cells after experimental allogeneic bone marrow transplantation.

Zeis M, Uharek L, Glass B, Vosskötter W, Dreger P, Schmitz N, Steinmann J. Zeis M, et al. Among authors: uharek l. Exp Hematol. 1998 Oct;26(11):1068-73. Exp Hematol. 1998. PMID: 9766447

6

Therapeutic spectrum in the treatment of myelodysplastic syndromes.

Hofmann WK, Baldus C, Uharek L, Thiel E. Hofmann WK, et al. Among authors: uharek l. Expert Opin Pharmacother. 2004 Dec;5(12):2451-8. doi: 10.1517/14656566.5.12.2451. Expert Opin Pharmacother. 2004. PMID: 15571463

7

Allogeneic MHC-mismatched activated natural killer cells administered after bone marrow transplantation provide a strong graft-versus-leukaemia effect in mice.

Zeis M, Uharek L, Glass B, Steinmann J, Dreger P, Gassmann W, Schmitz N. Zeis M, et al. Among authors: uharek l. Br J Haematol. 1997 Mar;96(4):757-61. doi: 10.1046/j.1365-2141.1997.d01-2101.x. Br J Haematol. 1997. PMID: 9074419 Free article.

8

Allogeneic hematopoietic cell transplantation following conditioning with 90Y-ibritumomab-tiuxetan.

Fietz T, Uharek L, Gentilini C, Muessig A, Rieger K, Marinets O, Sandrock D, Munz DL, Glass B, Thiel E, Blau IW. Fietz T, et al. Among authors: uharek l. Leuk Lymphoma. 2006 Jan;47(1):59-63. doi: 10.1080/10428190500260478. Leuk Lymphoma. 2006. PMID: 16321828

9

Angiotensin-(1-7) stimulates hematopoietic progenitor cells in vitro and in vivo.

Heringer-Walther S, Eckert K, Schumacher SM, Uharek L, Wulf-Goldenberg A, Gembardt F, Fichtner I, Schultheiss HP, Rodgers K, Walther T. Heringer-Walther S, et al. Among authors: uharek l. Haematologica. 2009 Jun;94(6):857-60. doi: 10.3324/haematol.2008.000034. Epub 2009 Apr 18. Haematologica. 2009. PMID: 19377080 Free PMC article.

10

Cytogenetic studies in acute leukemia patients relapsing after allogeneic stem cell transplantation.

Schmidt-Hieber M, Blau IW, Richter G, Türkmen S, Bommer C, Thiel G, Neitzel H, Stroux A, Uharek L, Thiel E, Blau O. Schmidt-Hieber M, et al. Among authors: uharek l. Cancer Genet Cytogenet. 2010 Apr 15;198(2):135-43. doi: 10.1016/j.cancergencyto.2010.01.005. Cancer Genet Cytogenet. 2010. PMID: 20362228

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters